bioAffinity Technologies, Inc. (BIAF) Operating income 2021–2025
bioAffinity Technologies, Inc. (BIAF) annual operating income history from SEC filings — each fiscal year as reported.
-$10.6MFY2025 · since FY2021: -$2.2M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.6M | -18.1% |
| FY2024 | -$9.0M | -12.3% |
| FY2023 | -$8.0M | -98.8% |
| FY2022 | -$4.0M | -81.8% |
| FY2021 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Net marginBIAF Gross profitBIAF Gross marginBIAF Operating marginBIAF Operating cash flowBIAF Free cash flowBIAF Capital expendituresBIAF Return on equityBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Total liabilitiesBIAF Shareholders’ equityBIAF overview →